A New Antileishmanial Preparation of Combined Solamargine and Solasonine Heals Cutaneous Leishmaniasis through Different Immunochemical Pathways

Little has been done during the past 100 years to develop new antileishmanial drugs. Most infected individuals live in poor countries and have a low cash income to be attractive targets to pharmaceutical corporations. Two heterosidic steroids, solamargine and solasonine, initially identified as majo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Lezama-Dávila, C. M., McChesney, J. D., Bastos, J. K., Miranda, M. A., Tiossi, R. F., da Costa, J. de C., Bentley, M. V., Gaitan-Puch, S. E., Isaac-Márquez, A. P.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862480/
https://ncbi.nlm.nih.gov/pubmed/26883711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02804-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars